Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| 1 |
Verizon
VZ
|
$521M |
| 2 |
Philip Morris
PM
|
$404M |
| 3 |
Kinder Morgan
KMI
|
$305M |
| 4 |
Visa
V
|
$296M |
| 5 |
Coca-Cola
KO
|
$273M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
$238M |
| 2 |
DuPont de Nemours
DD
|
$148M |
| 3 |
Johnson Controls International
JCI
|
$144M |
| 4 |
Darden Restaurants
DRI
|
$115M |
| 5 |
PepsiCo
PEP
|
$106M |
Sector Composition
| 1 | Healthcare | 15.15% |
| 2 | Financials | 12.73% |
| 3 | Technology | 10.47% |
| 4 | Energy | 10.23% |
| 5 | Industrials | 9.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Verizon
VZ
$186B
| $1.61B | 2.93% | 33,123,048 +10,704,740 | +48% | +$521M |
|
2
Microsoft
MSFT
$3.77T
| $1.41B | 2.56% | 34,563,367 +5,059,833 | +17% | +$206M |
|
3
Texas Instruments
TXN
$184B
| $1.37B | 2.5% | 24,017,589 +1,837,100 | +8% | +$105M |
|
4
ConocoPhillips
COP
$124B
| $1.08B | 1.97% | 17,425,459 +4,185,684 | +32% | +$261M |
|
5
Merck
MRK
$210B
| $1.05B | 1.92% | 18,342,875 +1,535,000 | +9% | +$88.2M |
|
6
Bristol-Myers Squibb
BMY
$96B
| $1.01B | 1.84% | 15,681,685 -111,500 | -0.7% | -$7.19M |
|
|
7
Coca-Cola
KO
$297B
| $1.01B | 1.83% | 24,843,345 +6,731,000 | +37% | +$273M |
|
8
Chevron
CVX
$324B
| $954M | 1.74% | 9,088,950 +5,420 | +0.1% | +$569K |
|
9
Wells Fargo
WFC
$263B
| $943M | 1.71% | 17,329,700 +1,806,800 | +12% | +$98.3M |
|
10
CME Group
CME
$96B
| $867M | 1.58% | 9,151,795 +2,270,900 | +33% | +$215M |
|
11
Home Depot
HD
$405B
| $835M | 1.52% | 7,345,470 -432,832 | -6% | -$49.2M |
|
12
AbbVie
ABBV
$372B
| $828M | 1.51% | 14,146,896 +1,634,901 | +13% | +$95.7M |
|
13
Lockheed Martin
LMT
$106B
| $820M | 1.49% | 4,041,729 +723,074 | +22% | +$147M |
|
14
Pfizer
PFE
$141B
| $810M | 1.47% | 23,289,231 +7,204,000 | +45% | +$251M |
|
|
15
Philip Morris
PM
$260B
| $762M | 1.39% | 10,113,006 +5,361,731 | +113% | +$404M |
|
16
Newell Brands
NWL
$2.48B
| $754M | 1.37% | 19,299,500 +60,000 | +0.3% | +$2.34M |
|
17
Enbridge
ENB
$105B
| $695M | 1.26% | 14,378,770 +3,147,100 | +28% | +$152M |
|
18
Procter & Gamble
PG
$368B
| $687M | 1.25% | 8,384,000 +66,730 | +0.8% | +$5.47M |
|
19
Goldman Sachs
GS
$226B
| $642M | 1.17% | 3,416,300 +34,100 | +1% | +$6.41M |
|
20
Gilead Sciences
GILD
$140B
| $616M | 1.12% | 6,278,500 -800,900 | -11% | -$78.6M |
|
21
Waste Management
WM
$91.2B
| $568M | 1.03% | 10,476,300 | – | – |
|
|
MON
22
DELISTED
Monsanto Co
MON
| $555M | 1.01% | 4,931,500 | – | – |
|
|
23
DuPont de Nemours
DD
$32.2B
| $550M | 1% | 11,456,452 -3,091,800 | -21% | -$148M |
|
24
Marsh & McLennan
MMC
$101B
| $543M | 0.99% | 9,677,194 +406,000 | +4% | +$22.8M |
|
25
Boeing
BA
$177B
| $517M | 0.94% | 3,446,600 -417,200 | -11% | -$62.6M |
|